Virtual assistant designed to support hematologists, adult and pediatric medical oncologists, internists, emergency physicians, nephrologists, hospital pharmacy professionals, and onco-hematology nursing staff in the risk assessment, prevention, diagnosis, treatment, and follow-up of tumor lysis syndrome, based on current evidence and guidelines up to August 2025.
Content automatically generated by an artificial intelligence system.It may contain inaccuracies.